What’s New in Pediatric Dermatology?
Abstract
A literature review was performed from January to December 2019 to describe what’s new in pediatric dermatology. This article is not a comprehensive review, it is meant to present new developments that may influence daily Canadian dermatology practice.
References
Zhong CS, Huang JT, Nambudiri VE. Revisiting the history of the 'Mongolian spot': The background and implications of a medical term used today. Pediatric Dermatology. 2019;36(5):755-757.
Prose NS. Bringing an end to the 'Mongolian Spot'. Pediatric Dermatology. 2019;36(5):758-758.
Stefanko NS, Drolet BA. Subcutaneous fat necrosis of the newborn and associated hypercalcemia: A systematic review of the literature. Pediatric Dermatology. 2019;36(1):24-30.
Kusari A, Han AM, Virgen CA, et al. Evidence-based skin care in preterm infants. Pediatric Dermatology. 2019;36(1):16-23.
Krowchuk DP, Frieden IJ, Mancini AJ, et al. Clinical Practice Guideline for the Management of Infantile Hemangiomas. Pediatrics. 2019;143(1):e20183475.
Dalla Costa R, Prindaville B, Wiss K. Doing the math: A simple approach to topical timolol dosing for infantile hemangiomas. Pediatric Dermatology. 2018;35(2):276-277.
Drolet BA, Boakye-Agyeman F, Harper B, et al. Systemic timolol exposure following topical application to infantile hemangiomas. J Am Acad Dermatol. 2020 Mar;82(3):733-736.
Randhawa HK, Sibbald C, García-Romero MT, Pope E. Oral Nadolol for the Treatment of Infantile Hemangiomas: A Single-Institution Retrospective Cohort Study. Pediatric Dermatology. 2015;32(5):690-695.
McGillis E, Baumann T, LeRoy J. Death Associated With Nadolol for Infantile Hemangioma: A Case for Improving Safety. Pediatrics. 2020;145(1):e20191035.
Thomas AC, Zeng Z, Riviere JB, et al. Mosaic Activating Mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis. J Invest Dermatol. 2016;136(4):770-778.
Klebanov N, Lin WM, Artomov M, et al. Use of Targeted Next-Generation Sequencing to Identify Activating Hot Spot Mutations in Cherry Angiomas. JAMA Dermatol. 2019;155(2):211-215.
Venot Q, Blanc T, Rabia SH, et al. Targeted therapy in patients with PIK3CA-related overgrowth syndrome. Nature. 2018;558(7711):540-546.
Lopez-Gutierrez J-C, Lizarraga R, Delgado C, et al. Alpelisib Treatment for Genital Vascular Malformation in a Patient with Congenital Lipomatous Overgrowth, Vascular Malformations, Epidermal Nevi, and Spinal/Skeletal Anomalies and/or Scoliosis (CLOVES) Syndrome. J Pediatr Adolesc Gynecol. 2019;32(6):648-650.
Atzmony L, Lim YH, Hamilton C, et al. Topical cholesterol/lovastatin for the treatment of porokeratosis: A pathogenesis-directed therapy. Journal of American Dermatology. 2020;82(1):123-131.
Paller AS, van Steensel MAM, Rodriguez-Martín M, et al. Pathogenesis-based therapy reverses cutaneous abnormalities in an inherited disorder of distal cholesterol metabolism. J Invest Dermatol. 2011;131(11):2242-2248.
Mir A, Agim NG, Kane AA, Josephs SC, Park JY, Ludwig K. Giant Congenital Melanocytic Nevus Treated With Trametinib. Pediatrics. 2019;143(3).
Cheong JYV, Hie SL, Koh EW, de Souza NNA, Koh MJ-A. Impact of pharmacists' counseling on caregiver's knowledge in the management of pediatric atopic dermatitis. Pediatric Dermatology. 2019;36(1):105-109.
Capozza K, Schwartz A. Does it work and is it safe? Parents’ perspectives on adherence to medication for atopic dermatitis. Pediatric Dermatology. 2020 Jan;37(1):58-61.
Karagounis TK, Gittler JK, Rotemberg V, Morel KD. Use of 'natural' oils for moisturization: Review of olive, coconut, and sunflower seed oil. Pediatric Dermatology. 2019;36(1):9-15.
Schachner LA. A 3-day rate of efficacy of a moderate potency topical steroid in the treatment of atopic dermatitis in infancy and childhood. Pediatric Dermatology. 1996;13(6):513-514.
Oberlin KE, Nanda S. Atopic dermatitis made easy: The Schachner Ladder. Pediatric Dermatology. 2019;36(6):1017-1018.
Anderson K, Putterman E, Rogers RS, Patel D, Treat JR, Castelo-Soccio L. Treatment of severe pediatric atopic dermatitis with methotrexate: A retrospective review. Pediatric Dermatology. 2019;61(774):656.
Chan S, Cornelius V, Cro S, Harper JI, Lack G. Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial. JAMA Pediatr. 2020 Jan 1;174(1):29-37.
Heil PM, Maurer D, Klein B, Hultsch T, Stingl G. Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course – a randomized, placebo-controlled and double blind pilot study. J Dtsch Dermatol Ges. 2010;8(12):990-998.
Iyengar SR, Hoyte EG, Loza A, et al. Immunologic effects of omalizumab in children with severe refractory atopic dermatitis: a randomized, placebo-controlled clinical trial. Int Arch Allergy Immunol. 2013;162(1):89-93.
Siegfried EC, Igelman S, Jaworsk JC, et al. Use of dupilimab in pediatric atopic dermatitis: Access, dosing, and implications for managing severe atopic dermatitis. Pediatric Dermatology. 2019;36(1):172-176.
Treister AD, Lio PA. Long-term off-label dupilumab in pediatric atopic dermatitis: A case series. Pediatric Dermatology. 2019;36(1):85-88.
Igelman S, Kurta AO, Sheikh U, et al. Off-label use of dupilumab for pediatric patients with atopic dermatitis: A multicenter retrospective review. Journal of American Dermatology. 2020;82(2):407-411.
Simpson EL, Paller AS, Siegfried EC, et al. Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial. JAMA Dermatol. 2020 Jan 1;156(1):44-56.
Groot J, Blegvad C, Nybo Andersen AM, Zachariae C, Skov L. Tonsillitis and pediatric psoriasis: Cohort and cross-sectional analyses of offspring from the Danish National Birth Cohort. Journal of American Dermatology. 2020 Mar;82(3):666-674.
Menter A, Cordoro KM, Davis DMR, et al. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. Journal of American Dermatology. 2020;82(1):161-201.
Lansang P, Bergman JN, Fiorillo L, et al. Management of Pediatric Plaque Psoriasis using Biologics. Journal of the American Academy of Dermatology. 2020 Jan;82(1):213-221.
Flores-Genuino RNS, Gnilo CMS, Dofitas BL. Occlusive versus neurotoxic agents for topical treatment of head lice infestation: A systematic review and meta-analysis. Pediatric Dermatology. 2020 Jan;37(1):86-92.
Dabas G, Vinay K, Mahajan R. Diffuse Hyperpigmentation in Infants During Monsoon Season. JAMA Dermatol. 2019;156(1):1-2.
Bhatia SS, Shenoi SD, Hebbar SA, Kayarkatte MN. The chik sign in dengue. Pediatric Dermatology. 2019;36(5):737-738.
Coulombe J, Belzile E, Duhamel A, et al. Pediatric SJS/TEN Subdued by a Combination of Dexamethasone, Cyclosporine, and Etanercept. J Cutan Med Surg. 2019;23(5):547-550.
Chafranska L, Saunte DM, Behrendt N, et al. Pediatric toxic epidermal necrolysis treated successfully with infliximab. Pediatric Dermatology. 2019;36(3):342-345.
Goyal A, Hook K. Two pediatric cases of influenza B-induced rash and mucositis: Stevens-Johnson syndrome or expansion of the Mycoplasma pneumoniae-induced rash with mucositis (MIRM) spectrum? Pediatric Dermatology. 2019;32(2):472.
Li HOY, Colantonio S, Ramien ML. Treatment of Mycoplasma pneumoniae-Induced Rash and Mucositis With Cyclosporine. J Cutan Med Surg. 2019;2(3):1203475419874444.
Bartenstein DW, Fisher JM, Stamoulis C, et al. Clinical features and outcomes of spitzoid proliferations in children and adolescents. British Journal of Dermatology. 2019;181(2):366-372.
Ciriacks K, Knabel D, Waite MB. Syndromes associated with multiple pilomatricomas: When should clinicians be concerned? Pediatric Dermatology. 2020 Jan;37(1):9-17.
Heller E, Murthy AS, Jen MV. A slime of the times: Two cases of acute irritant contact dermatitis from homemade slime. Pediatric Dermatology. 2019;36(1):139-141.
Mainwaring W, Zhao J, Hunt R. Allergic contact dermatitis related to homemade slime: a case and review of the literature. Dermatol Online J. 2019;25(4).
Zhang AJ, Boyd AH, Asch S, Warshaw EM. Allergic contact dermatitis to slime: The epidemic of isothiazolinone allergy encompasses school glue. Pediatric Dermatology. 2019;36(1):e37-e38.
Jacob SE. Homemade slime: A contact dermatitis 'perfect storm'. Pediatric Dermatology. 2019;36(3):338.
Salman A, Demir G, Apti O. 'Slime': A trending cause of isothiazolinone contact allergy in children. Contact Derm. 2019;80(6):409-411.
Anderson LE, Treat JR, Brod BA, Yu J. 'Slime' contact dermatitis: Case report and review of relevant allergens. Pediatric Dermatology. 2019;36(3):335-337.
Kondratuk KE, Norton SA. 'Slime' dermatitis, a fad-associated chronic hand dermatitis. Pediatric Dermatology. 2019;36(1):e39-e40.
Gittler JK, Garzon MC, Lauren CT. 'Slime' May Not be so Benign: A Cause of Hand Dermatitis. The Journal of Pediatrics. 2018;200:288.
Duplisea MJ, Flores K. Buzzing away the pain: Using an electric toothbrush for vibration anesthesia during painful procedures. Pediatric Dermatology. 2019;36(3):414-415.
Shih Y-H, Huang CY, Lee CC, Lee W-R. Nail Brace Application: A Noninvasive Treatment for Ingrown Nails in Pediatric Patients. Dermatol Surg. 2019;45(2):323-326.
Bagadia J, Jaiswal S, Bhalala KB, Poojary S. Pinch of salt: A modified technique to treat umbilical granuloma. Pediatric Dermatology. 2019;36(4):561-563.
Yale S, Stefanko N, McCarthy P, McFadden V, McCarthy J. Severe methemoglobinemia due to topical dapsone misuse in a teenage girl. Pediatric Dermatology. 2020 Mar;37(2):377-378.
Hoernke JM, Schoch JJ. The art of distraction: How to compile and use a distraction kit in pediatric dermatology. Pediatric Dermatology. 2019;10(29):1688.
Habeshian K, Silverman RA, DeKlotz CMC. Treatment of benign cephalic histiocytosis with topical 1% rapamycin ointment. Pediatric Dermatology. 2019;36(3):411-413.
Kosche C, Mansh M, Luskus M, et al. Dermatologic care of sexual and gender minority/LGBTQIA youth, Part 2: Recognition and management of the unique dermatologic needs of SGM adolescents. Pediatric Dermatology. 2019;36(5):587-593.
Boos MD, Yeung H, Inwards-Breland D. Dermatologic care of sexual and gender minority/LGBTQIA youth, Part I: An update for the dermatologist on providing inclusive care. Pediatric Dermatology. 2019;36(5):581-586.
Yeung H, Luk KM, Chen SC, Ginsberg BA, Katz KA. Dermatologic care for lesbian, gay, bisexual, and transgender persons: Terminology, demographics, health disparities, and approaches to care. Journal of the American Academy of Dermatology. 2019;80(3):581-589.
Yeung H, Luk KM, Chen SC, Ginsberg BA, Katz KA. Dermatologic care for lesbian, gay, bisexual, and transgender persons: Epidemiology, screening, and disease prevention. Journal of the American Academy of Dermatology. 2019 Mar;80(3):591-602.
